NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial | Kaiser Health News: The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.
No comments:
Post a Comment